The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 359:307-309 July 17, 2008 Number 3
NextNext

The Antiinflammatory IgG
Srini V. Kaveri, D.V.M., Ph.D., Sébastien Lacroix-Desmazes, Ph.D., and Jagadeesh Bayry, D.V.M., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Intravenous immune globulin is a therapeutic preparation of normal human polyclonal IgG obtained from plasma pooled from several thousand healthy blood donors. Initially used in treating primary and secondary immune deficiencies, intravenous immune globulin is increasingly used for the treatment of diverse autoimmune and systemic inflammatory diseases including immune thrombocytopenia, Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, dermatomyositis, and Kawasaki's syndrome.

Several non–mutually exclusive mechanisms have been proposed to explain the beneficial effects of intravenous immune globulin in patients.1 One such process was proposed by Ravetch et al. in 20062: that the beneficial effect of intravenous immune globulin . . . [Full Text of this Article]


Source Information

From the Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, Université Paris Descartes, Centre de Recherche des Cordeliers, Paris.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.